DcR3 regulates the growth and metastatic potential of SW480 colon cancer cells

被引：24

作者：

Yu, Wei ^{[1
]}

Xu, Ying-Chen ^{[2
]}

Tao, Ying ^{[1
]}

He, Ping ^{[2
]}

Li, Yang ^{[2
]}

Wu, Tao ^{[1
]}

Zhu, Yan-Pei ^{[1
]}

Li, Jing ^{[3
]}

Wu, Ji-Xiang ^{[4
]}

Dai, Jie ^{[1
]}

机构：

[1] Capital Med Univ, Ctr Clin Pathol, Beijing 100069, Peoples R China

[2] Capital Med Univ, Beijing Anzhen Hosp, Dept Gen Surg, Beijing 100029, Peoples R China

[3] Beijing Aerosp Gen Hosp, Dept Pathol, Beijing 100076, Peoples R China

[4] Capital Med Univ, Beijing Tongren Hosp, Beijing 100730, Peoples R China

来源：

ONCOLOGY REPORTS | 2013年 / 30卷 / 06期

基金：

中国国家自然科学基金;

关键词：

DcR3; colon cancer; RNAi; MMPs; VEGFs; DECOY RECEPTOR-3; CLINICAL-SIGNIFICANCE; ESOPHAGEAL-CARCINOMA; VEGF-D; PROLIFERATION; SUPERFAMILY; INHIBITION; EXPRESSION; MIGRATION; SURVIVAL;

D O I：

10.3892/or.2013.2769

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Decoy receptor 3 (DcR3) is considered to have anti-apoptotic and pro-metastatic functions, suggesting it might be a therapeutic target. We examined the role and mechanisms of DcR3 on growth and the metastatic ability of SW480 colon cancer cells to provide therapeutic information for targeting DcR3 by RNA interference (RNAi) technology. Growth and the metastatic ability were inhibited, apoptosis was induced and cell cycle profile was changed after decreasing DcR3 expression, with lower levels of vascular endothelial growth factors (VEGFs) and matrix metalloproteinases (MMPs) expression. Our results implied the therapeutic potential of silencing DcR3 expression by RNAi in colon cancer.

引用

页码：2741 / 2748

页数：8

共 50 条

[1] Effects of thalidomide on growth and VEGF-A expression in SW480 colon cancer cells
Zhang, Xin
Luo, Hesheng
ONCOLOGY LETTERS, 2018, 15 (03) : 3313 - 3320
[2] The tumorigenic, invasive and metastatic potential of epithelial and round subpopulations of the SW480 human colon cancer cell line
Yoon, Wan-Hee
Lee, Sang-Kwang
Song, Kyoung-Sub
Kim, Jong-Seok
Kim, Tae-Dong
Li, Ge
Yun, Eun-Jin
Heo, Jun-Young
Jung, Yeon-Joo
Park, Jong-Il
Kweon, Gi-Ryang
Koo, Sun-Hoe
Park, Hae-Duck
Hwang, Byung-Doo
Lim, Kyu
MOLECULAR MEDICINE REPORTS, 2008, 1 (05) : 763 - 768
[3] The Effect of Flubendazole on Adhesion and Migration in SW480 and SW620 Colon Cancer Cells
Hanusova, Veronika
Skalova, Lenka
Kralova, Vera
Matouskova, Petra
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (06) : 837 - 846
[4] Proteomic analysis identifies PFKP lactylation in SW480 colon cancer cells
Cheng, Zhe
Huang, Huichao
Li, Maoyu
Chen, Yongheng
ISCIENCE, 2024, 27 (01)
[5] Acetylcarnitine potentiates the anticarcinogenic effects of butyrate on SW480 colon cancer cells
Elimrani, Ihsan
Dionnei, Serge
Saragosti, Dan
Qureshi, Ijaz
Levy, Emile
Delvin, Edgar
Seidman, Ernest G.
INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (02) : 755 - 763
[6] Tumor Repressive Functions of Estrogen Receptor β in SW480 Colon Cancer Cells
Hartman, Johan
Edvardsson, Karin
Lindberg, Karolina
Zhao, Chunyan
Williams, Cecilia
Strom, Anders
Gustafsson, Jan-Ake
CANCER RESEARCH, 2009, 69 (15) : 6100 - 6106
[7] siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells
Zhou, Dong
Yang, Jie
Huang, Wei-Dong
Wang, Jun
Zhang, Qiang
WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (44) : 8108 - 8113
[8] siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells
Dong Zhou
Jie Yang
Wei-Dong Huang
Jun Wang
Qiang Zhang
World Journal of Gastroenterology, 2013, (44) : 8108 - 8113
[9] Knockdown of IGF-IR by RNAi Inhibits SW480 Colon Cancer Cells Growth In Vitro
Yavari, Kamal
Taghkhani, Mohammad
Maragheh, Mohammad Ghannadi
Mesbah-Namin, Seyed A.
Babaei, Mohammad Hosein
ARCHIVES OF MEDICAL RESEARCH, 2009, 40 (04) : 235 - 240
[10] Effect of lidocaine and ropivacaine on primary (SW480) and metastatic (SW620) colon cancer cell lines
Siekmann, Wiebke
Tina, Elisabet
Von Sydow, Anita Koskela
Gupta, Anil
ONCOLOGY LETTERS, 2019, 18 (01) : 395 - 401

← 1 2 3 4 5 →